De-cancer / curatio / medicinae / myeloma multa,
Medicamenta ad Multiple Myeloma Probatus Et Alia Cell Neoplasmata Plasma Pure
Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) pro plasma et alia multa myeloma cellula Neoplasmata maligna organorum. Album quod includit nomina systematica, notam nomen, et in commune medicamento nationibus, ad ostensionem quam maiusculis scribere litteris. Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. Medicinae non sit in cellula plasma et alia multa myeloma Neoplasmata maligna organorum, quae non enumerantur hic.
Medicamenta ad Multiple Myeloma Probatus Et Alia Cell Neoplasmata Plasma Pure
Quia Alkeran Injection (Melphalan Hydrochloride)
Alkeran Tabulettae (Melphalan)
Aredia (Pamidronate Peroxosulphates)
BiCNU (Carmustine)
Bortezomib
Carfilzomib
Carmustine
cyclophosphamide
Daratumumab
Darzalex (Daratumumab)
Doxil (Doxorubicin Hydrochloride Liposoma)
Doxorubicin Hydrochloride Liposoma
Elotuzumab
Empliciti (Elotuzumab)
Evomela (Melphalan Hydrochloride)
Farydak (Panobinostat)
Ixazomib Citrate
Kyprolis (Carfilzomib)
Lenalidomide
Melphalan
Melphalan Hydrochloride
Mozobil (Plerixafor)
Ninlaro (Ixazomib Citrate)
Pamidronate Peroxosulphates
Panobinostat
Plerixafor
Pomalidomide
Pomalyst (Pomalidomide)
Revlimid (Lenalidomide)
Selinexor
Thalidomide
Thalomid (Thalidomide)
Velcade (Bortezomib)
Xpovio (Selinexor)
Acidum Zoledronic
Zometa (Mors Zoledronic)
Alia pulchra medicamento expensis Multiple Myeloma et Cell Neoplasmata Plasma Pure
PULVINUS
